Vaccine Safety Insights
Pfizer and Moderna are closely monitoring trial participants for safety over an extended period, with most adverse effects typically occurring within the first two months. The FDA requires at least two months of data before considering emergency use authorization, but ongoing studies will help determine the long-term efficacy of these vaccines. Promising results suggest that authorization could happen soon, potentially leading to rapid distribution.In this clip
From this podcast
Chasing Life
Emergency Use Authorization Explained
Related Questions